In-depth research on therapeutic peptides including BPC-157, Semax, Selank, KPV, DSIP, and more. Explore mechanisms of action, clinical studies, dosing protocols, and safety profiles backed by published science.
Tirzepatide is the first dual GIP/GLP-1 receptor agonist approved by the FDA, producing weight loss and glycemic improvements that exceed every prior incretin therapy in head-to-head trials.
PT-141 (bremelanotide) is an FDA-approved melanocortin receptor agonist for hypoactive sexual desire disorder. Learn about its unique central nervous system mechanism.
MOTS-c is encoded in mitochondrial DNA and activates AMPK — the same metabolic sensor triggered by exercise. Research shows effects on insulin sensitivity, fat metabolism, and aging.
Ipamorelin selectively stimulates growth hormone release without affecting cortisol, prolactin, or appetite. Learn why it's considered the cleanest GH secretagogue available.
IGF-1 LR3 is a modified version of insulin-like growth factor with a significantly extended half-life. Explore its mechanisms for muscle growth, recovery, and cellular health.
Cagrilintide is a long-acting amylin analog being studied for weight management. Learn how it differs from GLP-1 drugs, its mechanisms, and what clinical trials show.
GHK-Cu is a naturally occurring copper peptide that declines with age. Research shows it modulates over 30% of human genes, shifting expression toward a younger pattern.
Tesamorelin is the only FDA-approved GHRH analog for reducing visceral fat. Explore the clinical research, mechanisms, and what makes this peptide unique.
KPV is a powerful anti-inflammatory tripeptide that inhibits NF-κB signaling. Research shows it reduces intestinal inflammation and modulates immune responses without immunosuppression.
TB-500 is a synthetic fragment of Thymosin Beta-4 that promotes cell migration, reduces inflammation, and accelerates tissue repair. Here's what the research shows.